Turkey to sign deal with Pfizer-BioNTech for 4.5 million doses of COVID-19 vaccine

FILE PHOTO: Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

ANKARA (Reuters) - Turkey will sign an agreement with Pfizer and BioNTech for 4.5 million doses of its COVID-19 vaccine to be delivered by the end of March, Health Minister Fahrettin Koca said on Thursday.

Speaking during a news conference, Koca said Turkey would have the option to procure 30 million more doses of the vaccine later on.

Turkey had agreed to procure 50 million doses of the COVID-19 vaccine developed by China’s Sinovac Biotech, which are expected to arrive on Monday, Koca said.

Reporting by Tuvan Gumrukcu and Ali Kucukgocmen; Editing by Alex Richardson